Aurinia Pharmaceuticals (NASDAQ:AUPH) reported quarterly earnings of $0.28 per share which beat the analyst consensus estimate of $0.24 by 16.67 percent. This is a 75 percent increase over earnings of $0.16 per share from the same period last year. The company reported quarterly sales of $83.220 million which beat the analyst consensus estimate of $79.357 million by 4.87 percent. This is a 18.87 percent increase over sales of $70.008 million the same period last year.